Stay Up to Date
with SHINE

Join Scott Shropshire and Katie Rittenhouse on an exclusive tour of SHINE Technologies' Systems and Manufacturing facility in Fitchburg, Wisconsin. This is where SHINE designs and builds systems for isotope production, neutron imaging and fusion neutron sources.

Building One is where SHINE's groundbreaking technologies are born. Take a tour of this facility with CEO Greg Peifer. See the world's brightest fusion neutron source, tritium and uranium labs, and a pilot plant for producing lutetium-177 for cancer treatment

FLARE is powerful enough to replace nuclear fission reactors in certain applications. It allows us to simulate the effect of a nuclear explosion on electronic components that are vital for our national defense systems. Watch the video tour led by SHINE founder and CEO, Greg Piefer.

Neutron imaging makes it possible to inspect thick metal parts in airplanes and other large machinery that must be extremely reliable. It can identify issues inside components that cannot be seen with other methods like X-rays. Take a look inside the facility with us.

SHINE employee Mindy Becker takes you on a virtual tour of our production process, showing how this "smart bomb" for cancer treatments goes from raw materials to life-saving therapies.

Cassiopeia is the largest Lu-177 production facility in the U.S. Here's a behind-the-scenes look at the facility, and the impact it will have on the fight against cancer!

Join Scott Shropshire and Katie Rittenhouse on an exclusive tour of SHINE Technologies' Systems and Manufacturing facility in Fitchburg, Wisconsin. This is where SHINE designs and builds systems for isotope production, neutron imaging and fusion neutron sources.

Neutron imaging makes it possible to inspect thick metal parts in airplanes and other large machinery that must be extremely reliable. It can identify issues inside components that cannot be seen with other methods like X-rays. Take a look inside the facility with us.

Incase you missed it, check out what it took to build our Lu-177 facility, Cassiopeia, and the impact that it will have on the market and cancer patients!

Fusion energy. That's the dream. It's why we're here. It's the purpose of our company, and not just to prove it scientifically, but to actually be able to commercialize it.

Phase 3: Recycling Nuclear Waste. "If that problem (of nuclear waste) could be solved, it certainly should make nuclear energy, and thus decarbonization, much more accessible. We want to take on that challenge."

Join us throughout this week as we dive deeper into the second phase of our business: Producing Medical Isotopes. We are combatting chronic shortages of nuclear medicine throughout the world. These shortages impact patient diagnoses and treatment of heart disease, cancer, and other serious illnesses.

Learn more about the first phase of our fusion technology business: Inspecting Industrial Components.

Using its proprietary technology, SHINE Technologies has demonstrated clearly visible Cherenkov radiation produced by fusion for what is believed to be the first time in history.

SHINE Technologies' non-carrier-added lutetium-177 production facility, which will operate at the company's headquarters in Janesville, Wisconsin, is expected to have an initial production capacity of 100,000 doses of Lu-177 per year, with the ability to further expand production capacity to 200,000 doses per year in the future.

Welcome to the world of fusion energy. Introducing Shine Technologies.

Ready to be inspired? Hear directly from Greg Piefer, the founder and CEO of SHINE Technologies, about the power of fusion energy to benefit humanity.